Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases
- PMID: 34431119
- DOI: 10.1002/hep.32117
Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases
References
-
- Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2019;69:394–419. https://doi.org/10.1002/hep.30145 - DOI
-
- US Food and Drug Administration . Due to risk of serious liver injury, FDA restricts use of Ocaliva (obeticholic acid) in primary biliary cholangitis (PBC) patients with advanced cirrhosis. https://www.fda.gov/drugs/drug‐safety‐and‐availability/due‐risk‐serious‐... . Accessed May 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical